# A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease

> **NCT07553377** · NA · NOT_YET_RECRUITING · sponsor: **Yale University** · enrollment: 50 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Alcohol Associated Liver Disease
- Medications for Alcohol Use Disorder
- Behavioral Medicine
- Medication Adherence

## Interventions

- **DEVICE:** AcamproSync

## Key facts

- **NCT ID:** NCT07553377
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-10
- **Primary completion:** 2030-10
- **Final completion:** 2030-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553377, "A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07553377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*